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Accessory Protein Facilitated CFTR-CFTR
Interaction, a Molecular Mechanism to Potentiate
the Chloride Channel Activity
1989). The cloned CFTR gene encodes a chloride chan-
nel that is activated by phosphorylation of the R domain
by cAMP-activated kinases (PKA), and agonistic ATP
binding to and hydrolysis by the NBD domain(s) (Frizzell
et al., 1986; Gadsby et al., 1995).
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725 North Wolfe Street The genetic cause of human cystic fibrosis by CFTR
mutations has been well established (see review by Zie-Baltimore, Maryland 21205
lenski and Tsui, 1995). Physiological experiments have
suggested that the native CFTR channel is a macromo-
lecular complex that can be regulated by various acces-Summary
sory-interacting proteins (see reviews by al-Awqati,
1995 and Wine, 1995). Like many other members of theThe cystic fibrosis transmembrane conductance regu-
lator (CFTR) gene encodes a chloride channel protein ABC transporter superfamily, the precise stoichiometry
of the CFTR channel is not known.that belongs to the superfamily of ATP binding cas-
sette (ABC) transporters. Phosphorylation by protein Using a combination of biochemical and molecular
techniques, we have identified a multivalent CFTR bind-kinase A in the presence of ATP activates the CFTR-
mediated chloride conductance of the apical mem- ing protein, CAP70, which is capable of facilitating inter-
molecular CFTR interaction. By directly testing its ef-branes. We have identified a novel hydrophilic CFTR
binding protein, CAP70, which is also concentrated fects on the CFTR channel activity, we found that
dimeric binding to the C terminus of CFTR by the recom-on the apical surfaces. CAP70 consists of four PDZ
domains, three of which are capable of binding to the binant CAP70 protein or a monoclonal antibody is suffi-
cient to potentiate the chloride current. Our resultsCFTR C terminus. Linking at least two CFTR molecules
via cytoplasmic C-terminal binding by either multiva- suggest that the CFTR channel is a dynamic macro-
molecular complex. The modulation of intermolecularlent CAP70 or a bivalent monoclonal antibody potenti-
ates the CFTR chloride channel activity. Thus, the contacts by a cytoplasmic accessory protein provides
a molecular basis for their functional plasticity.CFTR channel can be switched to a more active con-
ducting state via a modification of intermolecular
CFTR-CFTR contact that is enhanced by an accessory Results
protein.
Identification of CAP70
Introduction The C-terminal amino acid sequences of CFTR pre-
dicted from the cloned genes are highly conserved
The ATP binding cassette (ABC) superfamily proteins among many species (Figure 1a). To test the hypothesis
are important functional transporters in both prokary- that the C-terminal region may be involved in the interac-
otes and eukaryotes, playing the primary roles in mediat- tion with accessory proteins, an affinity column using
ing the entry and exit of a variety of molecules. They glutathione S-transferase (GST) fusion was constructed
form the largest group of paralogous proteins both in which contained the 15 C-terminal residues of the hu-
Escherichia coli with 80 members and in Bacillus subtilis man CFTR protein (Figure 1a). The binding proteins spe-
with 78 members, implicating their critical roles in cellu- cific for the CFTR affinity column were purified from
lar physiology. Although the precise number is currently mouse kidney extracts. When separated on SDS-PAGE,
unknown, existing information also suggests that this at least four polypeptides specific for the GST-CFTR
family of proteins is highly represented in the human column were identified. These CFTR-Associated Pro-
genome. Furthermore, abnormal function of ABC trans- teins (CAPs) had molecular masses of 40, 55, 70, and
porters has been directly linked to the causes of several 85 kDa (Figure 1b). The binding specificity to the CFTR
human diseases. C terminus was demonstrated by the restricted associa-
Cystic fibrosis (CF) is an autosomal recessive disorder tion with GST-CFTR beads, but not GST alone beads.
caused by mutations in the CFTR gene, which encodes The individual CAPs could interact either directly with
a chloride-conducting channel (Riordan et al., 1989; the CFTR C terminus or indirectly through association
Drumm et al., 1990; Rich et al., 1990). The CFTR protein with another CAP.
is a paradigmatic member of ABC transporters. Like On the basis of the intensity of the Coomassie stain,
other ABC transporters, CFTR comprises two hydropho- CAP70 was the most abundant polypeptide retained by
bic core regions, where each contains six putative mem- the affinity column and it thus served as a good candi-
brane-spanning segments and two nucleotide binding date for direct interaction with the CFTR C terminus.
domains (NBDs). Unique to CFTR is an additional large To determine the amino acid sequence, a large-scale
cytoplasmic domain (R domain) connecting the first and purification was carried out. The resultant purified pro-
second halves of the CFTR molecule (Riordan et al., teins were fractionated on SDS-PAGE, and transferred
and immobilized onto a polyvinylidene difluoride (PVDF)
membrane. To avoid potential N-terminal protection, the‡ To whom correspondence should be addressed: (e-mail: minli@
jhmi.edu). CAP70 polypeptide on the membrane was digested in
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Figure 1. Identification of CAP70
(a) Amino acid sequence alignment of the C
termini of CFTR from human (P13569), rat
(382755), mouse (M60439), rabbit (Q00554),
bovine (P35071), sheep (U20418), dogfish
(P26362), and Xenopus (U60209). The last 15
residues are bracketed. Conserved residues
are highlighted.
(b) Affinity purification of the CFTR-Associ-
ated Proteins (CAPs). The last 15 amino acids
of CFTR were fused to GST to form GST-
CFTR (1466-1480). Protein samples from dif-
ferent preparations (marked on the top) were
separated by SDS-PAGE and visualized by
Coomassie staining. Molecular weight stan-
dards and various CAPs are indicated on the
left and right sides of the panel, respectively.
(c) Deduced amino acid sequence of mouse
CAP70. The residues corresponding to the
two tryptic peptides from the purified CAP70
protein are underlined. The four PDZ do-
mains, PDZ1 to PDZ4, are highlighted in red.
Potential sites for phosphorylation by protein
kinase A and protein kinase C are marked
with blue and red dots, respectively.
situ and the released tryptic peptides were purified by liver, and small intestine (Figure 2a). To further inves-
tigate the expression pattern, an antibody againstHPLC. Microsequencing of internal tryptic peptides from
the purified CAP70 revealed two sequences of 26 resi- mCAP70 was developed and affinity purified. This anti-
body specifically recognized a 70 kDa polypeptide, anddues and 19 residues, respectively (Figure 1c). Although
the tryptic peptides did not identify any known genes strong immunoblot signals were consistently found in
kidney, liver, and small intestine. A significant amountin the database, comparison of the peptide sequences
with those in NCBI databases revealed several expres- of CAP70 protein could be detected in brain, lung, and
testis (Figure 2b). In addition, a relatively low level of 70sion sequence tag (EST) clones. The sequence analyses
of the full-length cDNA revealed that CAP70 was a kDa polypeptide could also be detected from pancreas,
stomach, and colon after longer exposure (data notmouse homolog of PDZK1. PDZK1 is a human gene
identified in a yeast two-hybrid screen using MAP17 as shown). The expression pattern of CAP70 partially over-
lapped with the tissue distribution of CFTR (Riordan etbait. MAP17 was initially identified by using the differen-
tial display technique that was selected for genes upreg- al., 1989; Trezise and Buchwald, 1991).
The subcellular localization of CAP70 was mainly re-ulated in renal cell carcinoma compared with normal
renal parenchyma. The function of MAP17 is currently stricted to apical domains of epithelial cells as demon-
strated by immunofluorescence staining (Figure 2c). Inunknown (Kocher et al., 1998).
CAP70 contained an open reading frame of 519 amino kidney and small intestine, a dense staining of CAP70
was colocalized along the brush border (apical mem-acids with a predicted molecular mass of 56 kDa. The
deduced mouse CAP70 (mCAP70) amino acid sequence brane domains) as revealed by the rhodamine-conju-
gated phloidin staining (Figure 2c, panels A–F). In kidney,contained the two tryptic peptides, which confirmed that
the two peptides were indeed derived from one protein the distribution of CAP70 was restricted mainly to the
proximal tubules. The surrounding glomerulus and other(Figure 1c). CAP70 protein comprises four PDZ domains,
which are also known as GLGF repeats, or disks-large tubular structures did not contain a significant level of
CAP70 (Figure 2c, panels A–C). In both tissue samples,homology repeats (DHRs) (see reviews by Kennedy,
1995 and Sheng, 1996). PDZ domains belong to a family the staining could be abolished by antigen, i.e., the puri-
fied CAP70 (data not shown). The tissue and subcellularof protein binding modules that have been shown to
interact with target proteins through binding either distribution of CAP70 was consistent with the CFTR
localization (Crawford et al., 1991; Trezise and Buch-to the C termini (Kim et al., 1995) or less commonly to
internal regions (van Huizen et al., 1998; Hillier et al., wald, 1991; Denning et al., 1992), thus in agreement with
the potential association of CAP70 with CFTR in vivo.1999). Recent reports have shown that PDZ domains
have diverse peptide binding specificity (Songyang et
al., 1997; Stricker et al., 1997). The tandem arrangement Interaction between CAP70 and CFTR
To determine whether and which region of CAP70 isof four PDZ domains suggests that CAP70 is likely to
function by binding to multiple proteins to organize a responsible for direct interaction with the C terminus
of CFTR, individual PDZ domains were expressed asmacromolecular complex.
Tissue distribution of the human CAP70 messenger hemagglutinin (HA) and green fluorescent protein (GFP)-
fusions in human embryonic kidney (HEK) 293 cells (Fig-RNA was examined using Northern blot analysis. The
2.7 kb CAP70 transcript was found mainly in kidney, ures 3a and 3b). The protein lysates of transfected
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Figure 2. Tissue Distribution and Subcellular Localization of CAP70
(a) Tissue distribution of CAP70 mRNA assayed by Northern blot analysis. Poly(A)1 RNA samples from indicated human tissues on the
nitrocellulose membrane (Origene Technologies Inc., MD) were hybridized with hCAP70 (upper panel). After removing the bound probe, the
filter was hybridized with a b-actin probe (bottom panel).
(b) Tissue distribution of the mCAP70 protein. Total protein lysates (20 mg protein) from the indicated tissues were separated by SDS-PAGE.
The mCAP70 protein was detected by immunoblot analysis using purified rabbit anti-CAP70 antibody. The molecular weight standards are
marked on the side.
(c) in vivo localization of mCAP70. Tissue sections from mouse kidney (A–C) and small intestine (D–F) were stained with anti-CAP70 antibody
(B and E). Rhodamine-conjugated phloidin (0.1 mg/ml, Sigma) was used to highlight the brush borders of kidney (A) and small intestine (D).
Overlays of anti-CAP70 and actin stainings are shown in panels (C) and (F). Bars 5 10 mm.
HEK293 cells were tested for association with the CFTR only upon the coexpression of CAP70 (Figure 3d, upper
panel). Substitution of the terminal TRL with TRA (HA-C terminus by an affinity “pull-down” assay. Figure 3b
shows that PDZ1, PDZ3, and PDZ4 could be precipitated CFTR-Ct*), which eliminated the CAP70-CFTR interac-
tion (data not shown), abolished the coprecipitation un-by glutathione agarose beads with bound GST fusion
of the CFTR C terminus (lanes 3), but not by GST beads der the same conditions (Figure 3d, lower panel). The
data show that CAP70 is capable of nucleating a proteinalone (lanes 2). The binding affinity (KD) was measured
by surface plasmon resonance (SPR) method using a complex that contains more than one CFTR C-terminal
domain. The recruitment of CFTR into the complex re-synthetic peptide (EEVQDTRL, C-peptide-TRL) corre-
sponding to the last eight amino acids of CFTR and quires its ability to bind to CAP70. We also attempted
the above experiment using differentially tagged full-the purified GST fusion proteins of the individual PDZ
domains (Figure 3a). The binding affinity varied from 8 length CFTR constructs. A combination of nonspecific
CFTR aggregation and differential expression level ofnM of PDZ3 to 220 nM of PDZ1. Mutation of C-peptide-
TRL to TRA abolished the interaction (data not shown). CAP70 and full-length CFTR fusions in transiently trans-
fected cells rendered the experiment unsuccessful (dataThus, the CFTR-CAP70 interaction could be mediated
through independent binding of the PDZ1, PDZ3, and not shown).
To further investigate the interaction of CAP70 withPDZ4 domains of CAP70 to the C terminus of CFTR.
The multivalent binding capability may provide a CFTR in a cellular environment, HEK293 cells were trans-
fected with functional GFP-CFTR in the presence ormechanism for CAP70 to assemble multiple CFTR mole-
cules. To test this hypothesis, we coexpressed CAP70 absence of CAP70. The transfected cells were lysed and
immunoprecipitated with an affinity-purified anti-CAP70in HEK293 cells with the CFTR C-terminal domains that
were differentially tagged with either HA epitope (HA- antibody. The immunoprecipitates were then labeled
with PKA in the presence of [33P]-g2ATP and resolvedCFTR-Ct) or green fluorescent protein (GFP-CFTR-Ct)
(Figure 3c). Multimerization of the CFTR C-terminal do- by SDS-PAGE. The GFP-CFTR fusion could be immuno-
precipitated with the anti-CAP70 antibody only in cellsmain by CAP70 was assessed based on whether HA-
CFTR-Ct can be coimmunoprecipitated with GFP- that were cotransfected with CFTR and CAP70 (Fig-
ure 3e).CFTR-Ct in the presence of CAP70. Figure 3d shows that
HA-CFTR-Ct was precipitated by an anti-GFP antibody To investigate the potential native association of
Cell
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Figure 3. Interaction between CAP70 and
CFTR
(a) Schematic diagrams of the constructs for
four GST-PDZ fusions. The amino acid posi-
tions corresponding to CAP70 coding se-
quence are indicated. CAP70 possesses
three distinct binding sites for CFTR and the
binding affinity (KD) is shown on the right.
(b) The affinity “pull-down” assay. The GST-
CFTR (1466-1480) bound beads were incu-
bated with cell lysates from four HA-GFP-
tagged PDZ domains as indicated on the top.
The expressed PDZ fusions (as shown in [a])
were detected with anti-HA monoclonal anti-
body. Lanes 1 are input lysates; lanes 2, pro-
teins bound to GST-beads; lanes 3, proteins
bound to GST-CFTR (1466-1480) beads.
(c) Schematic diagrams of GFP and HA-
fusions of the wild-type and mutant CFTR C
terminus. The amino acid positions corre-
sponding to the CFTR coding sequences are
indicated. The amino acid substitution of leu-
cine with alanine at the C-terminal end
(L1480A) was designated as HA-CFTR-Ct*.
(d) Multimerization of CFTR C termini by
CAP70. The cells were cotransfected with
various combinations of plasmids as indi-
cated on the top. Immunoprecipitates were
washed in the presence of 0.75 M NaCl, sepa-
rated by SDS-PAGE, and probed with the
anti-HA monoclonal antibody.
(e) Coimmunoprecipitation of CAP70 and
CFTR from transfected HEK293 cells. The
cells were transfected with various combina-
tions of plasmids as shown on the top. The
antibodies (z1 mg) used in immunoprecipita-
tion are indicated at the bottom. The immuno-
precipitates were radiolabeled by [g-33P]ATP
and PKA and resolved by 7.5% SDS-PAGE.
(f) Detection of CAP70 in Calu-3 cell lysates
by immunoblot analysis using an anti-human
CAP70 antibody (1:1000 dilution).
(g) Coimmunoprecipitation of CAP70 and
CFTR from the airway epithelial cell line,
Calu-3. The amount of antibodies and pro-
teins used in each reaction is as follows: 1 mg of anti-CFTR R/C terminus, 5 ml of preimmune serum, 1 mg of anti-human CAP70, 5 mg of
purified CAP70 and 2.5 mg of CFTR C-peptide-TRL. The immunoprecipitates were resolved by 5% SDS-PAGE, transferred to PVDF membrane,
and detected by immunoblot analysis using anti-CFTR C-terminal antibody (1:1000 dilution, Genzyme, MA).
(h) Colocalization of CFTR and CAP70 in primary cultured human bronchial airway epithelial cells. Cells were grown on collagen-coated cover
slips and stained with an anti-CFTR R domain antibody (1:200 dilution, Genzyme, MA) and an anti-hCAP70 antibody (1:100 dilution). The
specificity of anti-hCAP70 staining was tested by competition with excessive amount of antigen, i.e., CAP70. Colocalization of CAP70 (FITC-
labeled) with CFTR (Cy3-labeled) in the peripheral region indicated by arrows. Bar 5 5 mm.
CAP70 and CFTR, coimmunoprecipitation experiments than CFTR. Consistent with this notion, the result re-
vealed that CAP70 partially colocalized with CFTR inwere performed using human airway epithelial cell line
Calu-3, where functional expression of native CFTR was discrete small clusters in the peripheral region of the
cell (Figure 3h). The weaker staining signal of CFTRdetected (e.g., Shen et al., 1994) and CAP70 protein was
also found (Figure 3f). The CFTR protein was detected presumably resulted from the anti-R domain antibody
because anti-C terminus antibody, which recognizes thein the protein complex precipitated by anti-CAP70 anti-
body (Figure 3g). In contrast, the CFTR protein was not same epitope as CAP70, is not useful for this study.
Interestingly, CAP70-specific staining was also found indetectable using the preimmune serum. Furthermore,
the signal of CFTR coimmunoprecipitated by anti- the perinuclear region. In contrast, the CAP70 protein
in native tissue was restricted to apical region (FigureCAP70 antibody could be competed by the purified re-
combinant CAP70. The efficiency of the antigenic 2c). These results suggest that the localization of CAP70
and possibly the association of CFTR with CAP70 areCAP70 competition was further enhanced when the
CFTR binding sites in CAP70 were preblocked with ex- regulated in vivo.
cess amounts of the C-peptide-TRL.
The localization of native CAP70 and CFTR was exam- Potentiation of CFTR Channel Activity by CAP70
The functional effect of the CAP70 binding was exam-ined using confocal microscopy of immunofluorescence
stained primary culture derived from human bronchial ined by patch-clamp recording of the CFTR chloride
channel activity using transiently transfected HEK293epithelial cells. CAP70 is a protein that is more abundant
A Modulatory Protein for ABC Transporters
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Figure 4. Effect of CAP70 on the Wild-Type
CFTR Channel
(a) Expression and purification of recombi-
nant CAP70. GST-fusion of full-length CAP70
was expressed in E. coli and cleaved by
thrombin. The purified protein is shown after
separation by 10% SDS-PAGE and detected
by Coomassie staining. Molecular weight
standards are shown on the left in kDa.
(b) Continuous single channel trace recorded
in the presence of CAP70 alone and CAP70
with 75 nM PKA and 0.5 mM ATP. Arrows
indicate the time point when CAP70 and PKA/
ATP were added.
(c) Time course of Cl- current in excised in-
side-out macropatches recorded in symmet-
rical bath solution (150 mM NMDG-Cl) after
addition of 40 nM CAP70. Each data point
represents mean current during a 6 s interval.
75 nM PKA and 0.5 mM ATP were present at
all times as indicated by bars. The wash-out
was performed in the continuous presence of
PKA, ATP, and 400 nM of the CFTR C-pep-
tide-TRL.
(d) Effect of CAP70 on CFTR activity. Values
are mean current measured between 5 and
10 min after addition of CAP70. The asterisk
indicates statistical significance (p , 0.05).
(e) A continuous current trace of wild-type
CFTR channel from an excised inside-out
patch in the presence of 75 nM PKA and 0.5
mM ATP. CAP70 was added into bath solu-
tion in a step-wise fashion as indicated. The
selected traces representing in the absence
and presence of CAP70 are expanded.
(f and g) Open probability (Po) and mean open-
ing time (MOT) of the wild-type CFTR and
mutated CFTR-L1480A are plotted against
different concentrations of purified recombi-
nant CAP70 protein: filled squares, wild-type
CFTR plus CAP70; filled circles, CFTR
(L1480A) plus CAP70; open circles, wild-type
CFTR plus PDZ3-3. Effect of the concate-
nated PDZ3-3 protein on Po shown in (f). n for
wild-type CFTR is 5z9, for CFTR/L1480A is
4 and for PDZ3-3 is 5.
(h) All point histograms are shown. The
points/bin (vertical axis) are plotted against
current (horizontal axis). The concentrations
of CAP70 in each panel are as indicated.
(i) Dwell-time histograms are shown. The
points/bin (vertical axis) are plotted against
log dwell open time (horizontal axis). The
open time histograms were fit by a single ex-
ponential function. The concentrations of
CAP70 and time constants are as indicated
in each panel.
cells. The CFTR current is PKA- and ATP-dependent the GST portion by thrombin cleavage (Figure 4a). To
test whether the recombinant CAP70 has any effect onand present only in transfected cells. The authenticity
of the CFTR currents was further confirmed by the phar- the CFTR-mediated ion conducting activity, we studied
the channel behavior using both single channel re-macological behavior. The currents were insensitive to
4,49-diisothiocyanostilbene-2,29-disulfonic acid (DIDS) cording and macropatch recording techniques. Figure
4b shows a trace with typical CFTR characteristics, in-but could be inhibited by glybenclamide. The CAP70
used in this study was expressed in E. coli as a GST cluding linear current voltage relation, a 9.3 6 0.1 pS
(n 5 19) conductance and the PKA- and ATP-dependentfusion and was purified to homogeneity after removing
Cell
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Figure 5. Mapping the Minimal Region of
CAP70 Essential for Potentiation of CFTR
(a) Schematic diagrams of CAP70, PDZ3 (aa
231-348), PDZ1-2 (aa 1-230), PDZ2-3 (aa 119-
348), and PDZ3-4 (aa 231-474). PDZ domains
with CFTR binding ability are shown in red.
(b) Expression and purification of truncated
CAP70 proteins. GST fusion of various trun-
cated CAP70s were expressed in E. coli and
cleaved by thrombin. The purified proteins
were shown after separation by 12% SDS-
PAGE and detected by Coomassie staining.
(c-g) Representative traces of single CFTR
channel recordings in the absence (c) and
presence of 40 nM of various truncated
CAP70s: PDZ3 (d), PDZ1-2 (e), PDZ2-3 (f), and
PDZ3-4 (g). CFTR channels were activated
by PKA and ATP prior to the addition of the
truncated CAP70s.
(h) All point histograms are shown. The
points/bin (vertical axis) are plotted against
the current (horizontal axis). The concentra-
tions of purified PDZ3-4 in each panel are as
indicated.
(i) Comparison of open probability (Po) in the
presence of various truncated CAP70s. Data
shown are mean 6 SE of Po calculated from
3 min traces after the truncated CAP70s were
applied to the patches. The initial 30 s after
the addition of truncated CAP70s were ex-
cluded for the Po analyses. The asterisk indi-
cates statistical significance (p , 0.05). Num-
bers (n) of patches assayed are shown in
parentheses.
channel opening. In the absence of PKA and ATP, CAP70 nant CAP70, the CFTR channel was switched to a more
active state, where both open probability (Po) and meanalone was not sufficient to activate the channel and had
no effect on membrane conductance (Figure 4b). Under open time (MOT) increased in a dose-dependent manner
(Figures 4f and 4g, closed squares). The potentiationthe inside-out macropatch configuration, application of
CAP70 (40 nM) potentiated the CFTR chloride channel reached a maximum at 40 nM of CAP70. A higher con-
centration of CAP70 induced a decline from the maximalactivity by nearly 60% (Figures 4c and 4d). The maximal
potentiation was usually achieved in less than 5 min potentiation, suggesting that the stoichiometry of the
CAP70-CFTR complex plays a role in the optimal poten-(Figure 4c). The potentiation was reversed within 2–3
min when the patched membrane was perfused with the tiation (see Figure 7 and Discussion). The CAP70-medi-
ated potentiation was dependent on PKA and ATP. Incompetitive CFTR C-peptide.
To further characterize CAP70-mediated modulation, the presence of 200 nM of peptide, only C-peptide-TRL
(EEVQDTRL), and not mutated C-peptide-TRA (EEVQD-we studied the CAP70’s effects using single channel
recording techniques. The open probability (Po) of CFTR TRA), was able to abolish the CAP70-mediated poten-
tiation, consistent with the results of the binding ex-channel was typically 0.23 6 0.02 (n 5 19) in the pres-
ence of 0.5 mM ATP. Upon application of the recombi- periments (data not shown). In addition, amino acid
A Modulatory Protein for ABC Transporters
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Figure 6. Effect of the Monoclonal Antibody
on the CFTR Channel Activity
(a) The continuous traces represent 6 min re-
cordings in the absence and presence of 40
nM of a control anti-HA monoclonal antibody
(upper trace) and the monoclonal antibody
specific to the C terminus of CFTR (Genzyme,
MA) (bottom trace). The channel was acti-
vated in the presence of 75 nM PKA and 0.5
mM ATP. Addition of antibodies to the bath
solution is indicated by an arrow.
(b) All point histograms are shown. The
points/bin (vertical axis) are plotted against
the current (horizontal axis). The antibodies
used in the study are as indicated.
(c) Comparison of NPo in the absence and
presence of antibodies. Data shown are
mean 6 SE (n 5 3) of NPo calculated from the
3 min traces before and after the addition of
40 nM antibodies. The initial 30 ss after the
addition of antibodies were excluded for NPo
analysis. The asterisk indicates statistical sig-
nificance (p , 0.05).
substitution of the last residue leucine with alanine these possibilities, we tested the effect of a tandem
PDZ3 domain protein (PDZ3–3) on CFTR channel activ-(L1480A) in CFTR, which abolishes the binding to
CAP70, completely eliminated the CAP70-mediated po- ity. Figure 4f shows this tandem chimeric PDZ protein
indeed exhibited the potentiation activity, which is con-tentiation (Figures 4f and 4g, closed circles), suggesting
that the potentiation requires a direct interaction be- sistent with the notion that bivalent binding is responsi-
ble for the potentiation.tween CAP70 and the CFTR C terminus.
Purified CAP70 even at 250 nM behaved as a mono- To directly test whether the bivalent binding is suffi-
cient for the potentiation, we used a monoclonal anti-mer as tested by gel filtration chromatography (data
not shown). Results from the binding studies (Figure 3) body that recognized the last four residues (DTRL-
COOH) of CFTR. The bivalent binding by the antibodyshowed that there were three CFTR interacting PDZ
domains present in CAP70. To test for which one and would bring two CFTR molecules in proximity, reminis-
cent of the bivalent binding ability of PDZ3–4 or PDZ3–3.how many interacting PDZ domains are necessary for
the potentiation, the truncated CAP70 proteins corre- Figure 6a shows that this antibody, a completely unre-
lated protein to CAP70, could also potentiate the chan-sponding to PDZ1–2, PDZ2–3, PDZ3–4, and PDZ3
(Figure 5a) were expressed and purified to apparent nel activity (the lower trace). The antibody effects were
abolished by competition of 100 nM of the C-peptide-homogeneity (Figure 5b). These truncated proteins all
displayed the ability to bind the C terminus of CFTR TRL (data not shown). A control monoclonal antibody
(anti-HA tag) at the same concentration did not show(Figures 3a and 3b). PDZ3, PDZ1–2, and PDZ2–3 each
contain one CFTR binding site. When tested by excised any such effect (the upper trace). This result demon-
strated that the bivalent binding activity is sufficient forinside-out patch recording, these truncated proteins
were unable to induce any potentiation effect on the the potentiation, suggesting that CAP70 functions by mod-
ulating intermolecular CFTR-CFTR interaction. Such aCFTR channel (Figures 5c-5f, i). In contrast, PDZ3–4,
which contains two binding sites, displayed potentiation configuration of dimeric CFTR gives rise to more active
channels when activated by PKA and ATP.activity similar to that induced by the full-length CAP70
(Figures 5g-5i). These data showed that PDZ3–4 was
sufficient to exert the potentiation activity. Discussion
The potentiation activity of the PDZ3–4 fusion could
result from either bivalent binding of PDZ3–4 to two Structural studies of several prokaryotic ABC-like trans-
porters have provided important biochemical insightsCFTR molecules, possible potentiation sequence motifs
within the PDZ4 domain, or a combination of binding and into the function of this large family of proteins and their
potential relevance to mutations in ABC transporterspotentiation sequence motifs. To distinguish between
Cell
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that cause a variety of diseases (Armstrong et al., 1998;
Hung et al., 1998). Because these structures are either
partial or from nonparadigmatic transporters, the qua-
ternary structure of mammalian ABC transporters re-
mains largely unknown. Recent progress in low resolu-
tion structural studies has revealed images of purified
multidrug resistant P-glycoprotein, suggesting that the
monomeric form is sufficient for substrate binding and
ATP hydrolysis (Rosenberg et al., 1997).
The CFTR protein regulates and is regulated by a
variety of transporting processes. It has been specu-
lated that the CFTR quaternary structure may also un-
dergo dynamic changes. Thus, it is essential to deter-
mine the existence and organization of potential
heteromeric and homomeric CFTR interactions with
other functionally coupled proteins. Results consistent
with possible homomeric CFTR-CFTR interaction in-
clude the finding that a tandem fusion of two CFTR
coding sequences resulted in a functional channel which
exhibited one single unitary conductance identical to
that of CFTR (Zerhusen et al., 1999). In addition, electron
microscopy studies revealed that the CFTR channel on
the cell surface has a size that is considerably larger
than that of a monomer (Eskandari et al., 1998). The
result has also led to the suggestion that imaged parti-
cles are CFTR dimers. In contrast, biochemical studies
on purified or coimmunoprecipitated protein showed
that the purified recombinant CFTR protein is consistent
with the monomeric channel or an unstable oligomer
Figure 7. A Proposed Model of CAP70-Mediated Potentiation on
that could not survive the experimental procedures the CFTR Channel
(Marshall et al., 1994). Furthermore, the purified P-glyco-
CFTR monomers have an intrinsic ability to interact with each other.
protein was also seen as a monomer (Rosenberg et al., CAP70 facilitates the CFTR-CFTR interaction via bivalent binding
1997). A possible explanation for the existing data is to the C termini of CFTR. The dimerization of CFTR enhanced by
that the CFTR channel may interact to form a transitional CAP70 or monoclonal antibody allows for a more active channel
upon PKA and ATP stimulation. At high concentrations, CAP70 bind-dimer. Such a dimeric form is unstable, distinct from a
ing is mediated primarily via the PDZ3 domain, which has the highesttypical multimeric channel complex such as a voltage-
affinity. As a result, the bivalent binding is reduced and the channelgated potassium channel, where the purified recombi-
switches back to a less active state.
nant protein complex is stable and remains in a stoichi-
ometry identical to its native form (Li et al., 1994).
The potentiation by recombinant CAP70 was depen-
tration of CAP70 showed significantly reduced potentia-dent on the bivalent binding ability and not on a specific
tion (Figures 4f–4i). The third prediction from this modelpotentiation region of CAP70. Thus, modulation of the
is that a bivalent binding of two PDZ domains withintermolecular CFTR interaction is an attractive mecha-
equally high affinity would stabilize the CFTR-CFTR in-nism for the potentiation activity. Figure 7 shows a pro-
teraction. Therefore, we should not observe the afore-posed model for the CAP70-mediated potentiation. This
mentioned decline. Instead, the potentiation wouldmodel predicts that CFTR, in the absence of CAP70,
reach a plateau phase with a less pronounced declineexists either as a monomer or as a transient dimer when
phase even at higher concentrations. Consistent withactivated by PKA and ATP. In the presence of CAP70,
this prediction, the effect of the tandem PDZ protein ofthe formation of CAP70-(CFTR)1 allows for a more effec-
PDZ3-PDZ3 induced potentiation followed by a plateautive association with an additional CFTR molecule be-
phase at higher concentrations (Figure 4f, open circles).cause the bound CAP70 provides at least two possible
The binding affinity of PDZ3 is significantly higher thanbeneficial effects: (1) added affinity via either a PDZ1 or
that of PDZ1 or PDZ4 (Figure 3a). However, the concen-a PDZ4 association with another CFTR molecule, and (2)
tration of PDZ3-PDZ3 required for the maximal potentia-improved contact geometry between the two interacting
tion was not significantly lower than that of CAP70 de-CFTR molecules. The CAP70-configured (CFTR)2 com-
spite the expected higher affinity (avidity) to CFTR. Thisplex, when activated by PKA phosphorylation and ago-
inconsistency may be due to potential unfavorable con-nistic ATP, induces a more active CFTR channel. Thus,
straints as a result of the chimeric construction. Whilethe model also predicts that with an increasing CAP70
the mechanistic details by which CAP70 potentiates theconcentration, the highest affinity PDZ3 domain begins
CFTR channel require further investigation, it would beto dominate the binding. Under such conditions, al-
particularly interesting to test the potential role of thethough CAP70 remains in complex with CFTR, the biva-
parallel contact geometry of two NBD2 domains as alent CAP70-(CFTR)2 configuration is less favorable. As
result of CAP70 binding.a result, the potentiation by CAP70 will become less
pronounced. Consistent with this model, a high concen- A single conductance pore was observed by expres-
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the human CAP70. The Western blot analysis was performed assion of tandem dimeric CFTR constructs (Zerhusen et
described by Wang (Wang et al., 1998).al., 1999). While the data are consistent with the notion
of CFTR-CFTR intermolecular contacts, the engineered
Plasmid Constructioncovalent dimerization resulted in a less active channel.
Expression of GST, HA-tagged, or HA-GFP-tagged fusion was car-
Such a reduction is possibly due to unfavorable geome- ried out by high-fidelity PCR (ElongaseTM, Life Technology) with prim-
try as a result of the head–tail linkage of the two CFTR ers containing in-frame restriction enzyme sites. The PCR products
were digested and cloned into either a pGEX4T3 vector (Amersham-molecules, whereas both CAP70 and the antibody medi-
Pharmacia), a pCGN vector (Wang et al., 1998), or a pGFP vectorate a tail–tail configuration of the CFTR-CFTR inter-
(ClonTech Inc., CA). All PCR primer sequences are available uponaction.
request. Two PCR fragments, containing CAP70 coding sequencesIn addition to CAP70, Na1-H1 exchanger regulatory
of aa 231–361 and aa 231–348, were fused at the XbaI site in the
factor (NHE-RF), also known as EBP50 (ezrin binding pGEX4T3 vector to produce a GST-PDZ3–3 fusion protein. The full-
protein of 50 kDa), is the first protein to be reported to length CFTR was constructed into a pRSV vector as previously
described (Devidas et al., 1998). The CFTR-L1480A was derivedbind to the C terminus of CFTR (Hall et al., 1998; Short
from the pRSV-CFTR by replacing the HpaI/ApaI fragment with aet al., 1998; Wang et al., 1998). This protein contains
corresponding PCR fragment in which leucine 1480 was substitutedtwo PDZ domains (PDZ1 and PDZ2) with distinct peptide
with alanine. The resultant constructs were confirmed by DNA se-binding specificity as determined by random peptide
quencing.
display techniques; and the binding consensus of PDZ1
matches the sequence of the C terminus of CFTR (Wang Antibody Preparation
et al., 1998). Although the functional role and native To generate anti-sera against human and mouse CAP70 proteins,
the full-length cDNAs were subcloned into the pGEX4T3 vector. Theassociation of NHE-RF with CFTR have not been fully
GST-CAP70 fusion protein was used to immunize rabbits (Strategicestablished, the heterogeneity in tissue distribution and
Solutions, CA). The antisera were purified on affi-gel 15 columnsdomain organization of CAP70 and NHE-RF may allow
(Bio-Rad, CA) coupled with the purified CAP70 without GST. The
them to act differentially in different cells or combinatori- antibodies were sequentially eluted in 0.1 M glycine (pH 2.5) and
ally within the same cell. This would provide an advanta- 0.1 M triethylamine (pH 11.3). The eluates were neutralized with 1
geous mechanism to confer the diverse regulation of M Tris-HCl (pH 8.0). The specificity of the anti-CAP70 antibody was
determined by immunoblot analysis. Monoclonal antibodies specificthe CFTR protein in terms of both its subcellular tar-
for the C terminus and R domain of CFTR were purchased from thegeting and macromolecular organization.
Genzyme Corporation (MA). Anti-GFP antibody was purchased fromCytoplasmic binding of channel subunits by acces-
Clontech (Palo Alto, CA).
sory proteins has been seen in several systems including
postsynaptic density 95 (PSD-95) mediated specific In Vitro Binding
subcellular organization of potassium channel and To determine the affinity between CAP70 and CFTR, individual PDZ
NMDA receptors (Kim et al., 1995; Kornau et al., 1995). domains were expressed in E. coli and affinity purified using glutathi-
one-agarose beads. The affinity of the CAP70-CFTR associationOur data suggest that, in addition to their cellular func-
was measured by the surface plasmon resonance (SPR) methodtions such as specifying subcellular localization and reg-
using purified GST fusion proteins (as indicated) and a syntheticulating channel density, accessory proteins may also
peptide corresponding to the last eight residues of CFTR. The affinity
provide a structural framework to establish conducting pull-down experiments were carried out according to procedures
geometry and stoichiometry of ion channel and trans- that are essentially identical to those used in the CAP70 purification.
porter complexes that control and regulate their func-
tional heterogeneity. Coimmunoprecipitation
Calu-3 and transfected HEK293 cells were used for coimmuno-
precipitation. Cells were washed twice with PBS and lysed in HNT
Experimental Procedures lysis buffer as described above. The supernatant was collected after
centrifugation of the lysate at 27,000 3 g for 1 min at 48C and then
Purification of CAPs and Molecular Cloning of CAP70s first incubated with the affinity-purified antibodies at 48C for 1 hr,
Mouse kidney extracts were prepared by homogenization in HNT and subsequently, incubated with 40 ml of a 1:1 slurry of protein G
buffer containing 20 mM HEPES-KOH (pH 7.5), 120 mM NaCl, 1% or protein A-Sepharose for 16 hr at 48C. The protein A or G-antibody
Triton X-100, 5 mM EDTA, 0.5 mM dithiothreitol (DTT), and a cocktail complex was spun down at 4000 3 g for 1 min. The beads were
of protease inhibitors. The supernatant was collected after centrifu- washed once with HNT buffer, twice with HNT buffer supplemented
gation of the lysate at 27,000 3 g for 15 min at 48C and incubated with with 0.5 M NaCl, and three times with HNT buffer without Triton
a GST or GST-CFTR fusion protein bound to glutathione-agarose X-100. To radioactively label the CFTR protein, the immunoprecipi-
beads. After gentle rotation for 1 hr at 48C, the beads were washed tates were incubated for 1 hr at 308C in 20 ml of reaction mix con-
at 48C, once with HNT buffer, twice with HNT buffer supplemented taining 50 mM Tris-HCl (pH 7.5), 10 mM MgCl2, 0.1 mg/ml BSA, 10with 0.5 mM NaCl, and three times with HNT buffer without Triton
mCi of [33P]- g2ATP and 10 units of PKA (Sigma, MO). The beads
X-100. Prior to SDS-polyacrylamide gel electrophoresis (PAGE), the were washed twice with HNT buffer. The bound material was eluted
bound material was eluted with an SDS sample buffer. After electro- with the SDS sample buffer, then separated by SDS-PAGE. The
phoretic transfer to the PVDF membrane, the membrane-bound pro- precipitated CFTR signal was detected by either autoradiography
teins were identified. The area corresponding to the CAP70 poly- or immunoblot.
peptide was collected and subjected to tryptic digestion. After
purification by HPLC, peptide sequences were determined by micro-
Immunohistochemistry and Confocal Microscopysequencing (Wistar Institute, PA). The partial cDNA fragments were
Immunofluorescence was performed on 10 mm cryo-sections ofidentified from EST database with the peptide sequences. The full-
mouse kidney and small intestines. Sections were fixed and stainedlength mCAP70 cDNA was cloned from a kidney cDNA library.
with affinity-purified antibodies according to the standard methods
(Ausubel et al., 1993). Confocal microscopy was performed on a
Noran “OZ” confocal system and an Olympus inverted microscopeNorthern and Western Blots
Northern blots containing 2 mg of human mRNA from multiple tissues using an Olympus 603 or 1003 oil immersion objective lens. Double-
stained specimens were excited at 488 nm (FITC) and 568 nm (Rho-(Origene Technologies Inc., MD) were hybridized under high strin-
gency with a 32P-labeled probe made with the coding sequence of damine) using a Kr/Ar laser with FITC-narrow and rhodamine-narrow
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filter sets. Images were collected and processed, and merged in conductance regulator in chloride secretory epithelia. J. Clin. Invest.
89, 339–349.Noran Intervision software.
Devidas, S., Yue, H., and Guggino, W.B. (1998). The second half of
the cystic fibrosis transmembrane conductance regulator forms aPatch-Clamp Recording
functional chloride channel. J. Biol. Chem. 273, 29373–29380.Single-channel patch-clamp recording was carried out in the ex-
cised inside-out patch-clamp configuration by using conventional Drumm, M.L., Pope, H.A., Cliff, W.H., Rommens, J.M., Marvin, S.A.,
procedures. Human CFTR was expressed transiently in human em- Tsui, L., Collins, F.S., Frizzell, R.A., and Wilson, J.M. (1990). Correc-
bryonic kidney (HEK293) cells using the LipofectAMINETM reagent tion of the cystic fibrosis defect in vitro by retrovirus-mediated gene
(Gibco BRL, NY). Cells were routinely recorded at 36–72 hr after transfer. Cell 62, 1227–1233.
transfection. Patch-clamp pipette electrodes were prepared using Eskandari, S., Wright, E.M., Kreman, M., Starace, D.M., and Zam-
a two-stage vertical puller. When filled with the pipette solution, pighi, G.A. (1998). Structural analysis of cloned plasma membrane
their resistance was 2–5 mV for macropatches or 10–20 mV for proteins by freeze-fracture electron microscopy. Proc. Natl. Acad.
single channel patches. The seal resistance was 5–25 GV for macro- Sci. USA 95, 11235–11240.
patches and 10–100 GV for single channel patches. The bath solu-
Frizzell, R.A., Rechkemmer, G., and Shoemaker, R.L. (1986). Alteredtion contained 150 mM N-methyl-D-glutamine chloride, 1.1 mM
regulation of airway epithelial cell chloride channels in cystic fibro-MgCl2, 2 mM EGTA, and 10 mM TES (pH 7.35 with Tris); the pipette
sis. Science 233, 558–560.solution contained 150 mM N-methyl-D-glutamine chloride, 0.5 mM
Gadsby, D.C., Nagel, G., and Hwang, T.C. (1995). The CFTR chlorideMgCl2, and 10 mM TES (pH 7.35 with Tris). To activate the CFTR
channel of mammalian heart. Annu. Rev. Physiol. 57, 387–416.channels, catalytic subunits of protein kinase A (75 nM, Promega,
WI) and Mg21-ATP (0.5 mM, Sigma) were added to the bath solution Hall, R.A., Ostedgaard, L.S., Premont, R.T., Blitzer, J.T., Rahman,
of the excised inside-out patches. All single channel patch-clamp N., Welsh, M.J., and Lefkowitz, R.J. (1998). A C-terminal motif found
studies were performed at 258C. The voltage was held at 250 mV. in the b2-adrenergic receptor, P2Y1 receptor and cystic fibrosis
Currents were amplified with an Axopatch 200B patch-clamp ampli- transmembrane conductance regulator determines binding to the
fier and recorded on videotape for later analysis. Data were low-pass Na1/H1 exchanger regulatory factor family of PDZ proteins. Proc.
filtered at 100 Hz, digitized at 1 kHz, and analyzed by pCLAMP6.03 Natl. Acad. Sci. USA 95, 8496–8501.
software. For analysis of open probability and open-close kinetics, Hillier, B.J., Christopherson, K.S., Prehoda, K.E., Bredt, D.S., and
patches containing less than four channels were used. The number Lim, W.A. (1999). Unexpected modes of PDZ domain scaffolding
of channels in each patch was determined from the maximum num- revealed by structure of nNOS-syntrophin complex. Science 284,
ber of simultaneous channel openings observed during the course 812–815.
of an experiment that typically lasted 15–45 min. Po was calculated
Hung, L.W., Wang, I.X., Nikaido, K., Liu, P.Q., Ames, G.F., and Kim,from a current recording of at least 3 min duration. Lists of open
S.H. (1998). Crystal structure of the ATP-binding subunit of an ABCand closed times were created using a conventional half-amplitude
transporter . Nature 396, 703–707.crossing criterion for event detection. Transitions of less than 1 ms
Kennedy, M.B. (1995). Origin of PDZ (DHR, GLGF) domains. Trendsduration were excluded from the analysis. Results are expressed as
Biochem. Sci. 20, 350.mean 6 SE of n observations. Statistical significance was assessed
using a paired or unpaired Student’s t test as appropriate. Differ- Kim, E., Niethammer, M., Rothschild, A., Jan, Y.N., and Sheng, M.
ences were considered statistically significant when p , 0.05. (1995). Clustering of Shaker-type K1 channels by interaction with
a family of membrane-associated guanylate kinases. Nature 378,
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